Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
- Status
- COMPLETED
- Phase
- PHASE1
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)
- Status
- TERMINATED
- Phase
- PHASE1
A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
- Status
- COMPLETED
- Phase
- PHASE1
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
- Status
- COMPLETED
- Phase
- PHASE1
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
- Status
- RECRUITING
- Phase
- PHASE2
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
- Status
- RECRUITING
- Phase
- PHASE1
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
- Status
- TERMINATED
- Phase
- PHASE1
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
- Status
- COMPLETED
- Phase
- PHASE3